Validation of the French version of the PAWSS scale for alcohol withdrawal prediction
Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)
This study is testing a French version of a scale to see if it can accurately predict alcohol withdrawal symptoms in people with alcohol use disorders who are in the hospital.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 545 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Etablissement Public de Santé Barthélemy Durand Academic / other |
| Locations | 1 site (Étampes) |
| Trial ID | NCT06675539 on ClinicalTrials.gov |
What this trial studies
This observational study aims to validate the French version of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in patients with Alcohol Use Disorders (AUDs). Participants will be hospitalized and followed for three days, during which they will complete various scales and surveys, including the French PAWSS and other relevant assessments. The study seeks to determine if the psychometric properties of the French version are comparable to those of the English version, thereby enhancing the management of alcohol withdrawal syndrome in French-speaking populations.
Who should consider this trial
Good fit: Ideal candidates include male and female patients aged 18 to 60 with diagnosed alcohol use disorders who are hospitalized for withdrawal or related reasons.
Not a fit: Patients who are scheduled for discharge within 48 hours or those with uncontrolled epilepsy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the prediction and management of alcohol withdrawal severity in French-speaking patients, leading to better clinical outcomes.
How similar studies have performed: Previous studies have shown success with the PAWSS scale in English-speaking populations, but this validation for the French version is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, aged 18 to 60 years * Subjects with DSM-5 criteria for alcohol use disorders (AUD) * Subjects hospitalized for scheduled withdrawal or patients developing alcohol withdrawal hospitalized for another reason. * Subjects who understand French * Subject affiliated to the French social security system * Subject having given their written consent to the study Exclusion Criteria: * Subjects transferred from other hospitalization services for whom a withdrawal syndrome could have already been treated. * Subjects scheduled for discharge within 48 hours. * Subjects with known uncontrolled epilepsy. * Subjects unable to understand the questionnaire. * Subjects unable to give consent or not volunteering for the study. * Subjects under guardianship or curatorship.
Where this trial is running
Étampes
- Etablissement Public de Santé Barthélemy Durand — Étampes, France (Recruiting)
Study contacts
- Principal investigator: Alain Dervaux — Etablissement Public de Santé Barthélemy Durand
- Study coordinator: Adelaide Aduayi
- Email: adelaide.aduayi@eps-etampes.fr
- Phone: +33 1 75 02 16 81
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.